Melanoma News and Research

Latest Melanoma News and Research

Five new ways individualized medicine has moved from research lab into clinical care

Advancements in individualized medicine are offering health care providers new tools to quickly and accurately diagnose, treat, predict and, eventually, prevent disease. Keith Stewart, M.B., Ch.B., Carlson and Nelson Endowed Director, Mayo Clinic Center for Individualized Medicine, today outlined five new ways individualized medicine has moved from the research lab into clinical care. Dr. Stewart made his statements during the opening of the 2017 "Individualizing Medicine Conference: Advancing Care Through Genomics" in Rochester.

9 Oct 2017

Good-guy bacteria may help individuals respond well to cancer immunotherapy

Individuals with certain types of bacteria in their gut may be more likely to respond well to cancer immunotherapy, researchers at the Harold C. Simmons Comprehensive Cancer Center found in a study of patients with metastatic melanoma.

5 Oct 2017

Study sheds light on complex process involved in development of sperm stem cells

New research from scientists at Huntsman Cancer Institute at the University of Utah and collaborators at University of Utah Health sheds light on the complex process that occurs in the development of human sperm stem cells.

5 Oct 2017

Medicaid patients with melanoma more likely to experience surgical treatment delays

A retrospective review of several thousand melanoma cases in North Carolina found that Medicaid patients were more likely to experience surgical treatment delays than patients with private insurance, according to a study by University of North Carolina Lineberger Comprehensive Cancer Center researchers.

4 Oct 2017

Benefits of Biomarkers in Colorectal Cancer Treatment

Biomarkers fall into different categories: diagnostic biomarkers, are used to identify a disease; prognostic biomarkers, help clinicians to determine, for example, whether you're more likely to die or have problems with a disease; and there are some that can be used to inform treatment, to determine whether one therapy would be more successful than another.

2 Oct 2017

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.

27 Sep 2017

Study explores how tattoos may influence medical student's understanding of melanoma diagnosis

CANCER is on the rise and the need to be empathetic when giving a patient their diagnosis and throughout treatment is imperative.

26 Sep 2017

Study identifies slowly proliferating and highly invasive melanoma cells

A study conducted at The Wistar Institute has led to the identification of a slowly proliferating and highly invasive melanoma cell subpopulation, characterized by production of a protein associated with invasive behavior. The research was published in the journal Oncogene.

21 Sep 2017

Poliovirus therapy triggers longer-lasting immune response against malignant tumors

An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body's own capacity to fight malignancies by activating an inflammation process that counter's the ability of cancer cells to evade the immune system.

20 Sep 2017

Penn researchers identify new way to target enzyme crucial to tumor growth, develop new drugs

Opening up a new pathway to fight cancer, researchers at the University of Pennsylvania have found a way to target an enzyme that is crucial to tumor growth while also blocking the mechanism that has made past attempts to target that enzyme resistant to treatment.

20 Sep 2017

Researchers identify role of tumor-infiltrating B-cells in melanoma progression, resistance to therapy

In a multi-institutional collaborative study, scientists at The Wistar Institute and the Medical University of Vienna, Austria, have identified the role of tumor-infiltrating or tumor-associated B-cells ("TABs") in melanoma progression and resistance to targeted therapy.

20 Sep 2017

UTSW receives $34 million CPRIT award for cancer research and faculty recruitment

The Cancer Prevention and Research Institute of Texas has awarded UT Southwestern researchers more than $34 million for cancer research and faculty recruitment, including support for programs in pancreatic cancer, lung cancer, breast cancer, and melanoma.

19 Sep 2017

Cancer-fighting cells destroy tumors more effectively after being starved for oxygen

Mountain climbers and endurance athletes are not the only ones to benefit from altitude training - that is, learning to perform well under low-oxygen conditions.

18 Sep 2017

Ultraviolet LEDs more efficient than sunlight at producing vitamin D3 in the skin

Research published today in Scientific Reports shows that light from RayVio's 293nm ultraviolet (UV) LED is more efficient than sunlight at producing vitamin D3 in skin samples.

14 Sep 2017

Combination immunotherapy shows better overall survival in kidney cancer patients

A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.

13 Sep 2017

Melanoma News and Research

Latest Melanoma News and Research

Five new ways individualized medicine has moved from research lab into clinical care

Good-guy bacteria may help individuals respond well to cancer immunotherapy

Study sheds light on complex process involved in development of sperm stem cells

Medicaid patients with melanoma more likely to experience surgical treatment delays

Benefits of Biomarkers in Colorectal Cancer Treatment

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Study explores how tattoos may influence medical student's understanding of melanoma diagnosis

Study identifies slowly proliferating and highly invasive melanoma cells

Poliovirus therapy triggers longer-lasting immune response against malignant tumors

Penn researchers identify new way to target enzyme crucial to tumor growth, develop new drugs

Researchers identify role of tumor-infiltrating B-cells in melanoma progression, resistance to therapy

UTSW receives $34 million CPRIT award for cancer research and faculty recruitment

Cancer-fighting cells destroy tumors more effectively after being starved for oxygen

Ultraviolet LEDs more efficient than sunlight at producing vitamin D3 in the skin

Combination immunotherapy shows better overall survival in kidney cancer patients

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

Australian researchers make ultimate move in the battle against melanoma

Study findings may have critical implications to boost efficacy of T cell-based therapies

Study identifies late effects that may interfere with work status of young adult cancer survivors

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Melanoma News and Research

Latest Melanoma News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in